Citations (96)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (20)
Jiangtao Lin, Xin Zhou, Changzheng Wang, Chuntao Liu, Shaoxi Cai & Mao Huang. (2018) Symbicort® Maintenance and Reliever Therapy (SMART) and the evolution of asthma management within the GINA guidelines. Expert Review of Respiratory Medicine 12:3, pages 191-202.
Read now
Read now
Hiroshi Chantaphakul & Kiat Ruxrungtham. (2016) Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma. Expert Opinion on Pharmacotherapy 17:5, pages 631-642.
Read now
Read now
Heather E Hoch & Stanley J Szefler. (2016) Intermittent steroid inhalation for the treatment of childhood asthma. Expert Review of Clinical Immunology 12:2, pages 183-194.
Read now
Read now
David Hodgson, Kevin Mortimer & Tim Harrison. (2010) Budesonide/formoterol in the treatment of asthma. Expert Review of Respiratory Medicine 4:5, pages 557-566.
Read now
Read now
Shu Zhang, Xiaoning Zeng, Jifu Wei, Shan Li & Shaoheng He. (2010) Analysis of patents on anti-allergic therapies issued in China from 1988 to 2008. Expert Opinion on Therapeutic Patents 20:6, pages 727-737.
Read now
Read now
William E. Berger & Michael J. Noonan. (2010) Treatment of Persistent Asthma With Symbicort® (Budesonide/Formoterol Inhalation Aerosol): An Inhaled Corticosteroid and Long-Acting β2-Adrenergic Agonist in One Pressurized Metered-Dose Inhaler. Journal of Asthma 47:4, pages 447-459.
Read now
Read now
Kevin R Murphy & Bruce G Bender. (2009) Treatment of moderate to severe asthma: patient perspectives on combination inhaler therapy and implications for adherence. Journal of Asthma and Allergy 2, pages 63-72.
Read now
Read now
Christina Lee & Jonathan Corren. (2008) Budesonide/formoterol in the treatment of asthma. Expert Review of Respiratory Medicine 2:5, pages 551-564.
Read now
Read now
David MG Halpin. (2008) Symbicort: a pharmacoeconomic review. Journal of Medical Economics 11:2, pages 345-362.
Read now
Read now
Olof Selroos. (2007) A smarter way to manage asthma with a combination of a long-acting β2-agonist and inhaled corticosteroid. Therapeutics and Clinical Risk Management 3:2, pages 349-359.
Read now
Read now
R Buhl & C Vogelmeier. (2007) Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma. Current Medical Research and Opinion 23:8, pages 1867-1878.
Read now
Read now
Steven J. Edwards, Kevin Gruffydd-Jones & Dermot P. Ryan. (2007) Systematic review and meta-analysis of budesonide/formoterol in a single inhaler. Current Medical Research and Opinion 23:8, pages 1809-1820.
Read now
Read now
Iolo Doull, David Price, Mike Thomas, Neil Hawkins, Eugena Stamuli, Maggie Tabberer, Toby Gosden & Helen Rudge. (2007) Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma. Current Medical Research and Opinion 23:5, pages 1147-1159.
Read now
Read now
Mirjam Mensing & René Aalbers. (2007) Comparison and optimal use of fixed combinations in the management of COPD. International Journal of Chronic Obstructive Pulmonary Disease 2:2, pages 107-116.
Read now
Read now
Mikael Lundborg, Sören Wille, Leif Bjermer, Björn Tilling, Michael Lundgren, Gunilla Telg, Tommy Ekström & Olof Selroos. (2006) Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma:an efficacy and cost-effectiveness study. Current Medical Research and Opinion 22:5, pages 809-821.
Read now
Read now
Mario Cazzola, Maria Gabriella Matera & Jan Lötvall. (2005) Ultra long-acting β2-agonists in development for asthma and chronic obstructive pulmonary disease. Expert Opinion on Investigational Drugs 14:7, pages 775-783.
Read now
Read now
Jaro Ankerst. (2005) Combination Inhalers Containing Inhaled Corticosteroids and Long-Acting β2-Agonists: Improved Clinical Efficacy and Dosing Options in Patients with Asthma. Journal of Asthma 42:9, pages 715-724.
Read now
Read now
Jan Lötvall. (2004) Combination therapy in asthma -fixed or variable dosing in different patients?. Current Medical Research and Opinion 20:11, pages 1711-1727.
Read now
Read now
David Price, John Haughney, Adam Lloyd, Julia Hutchinson & Jonathan Plumb. (2004) An economic evaluation of adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study. Current Medical Research and Opinion 20:10, pages 1671-1679.
Read now
Read now
R. Scicchitano, R. Aalbers, D. Ukena, A. Manjra, L. Fouquert, S. Centanni, L.-P. Boulet, I. P. Naya & C. Hultquist. (2004) Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Current Medical Research and Opinion 20:9, pages 1403-1418.
Read now
Read now
Articles from other publishers (76)
Yuji Oba, Sumayya Anwer, Tinashe Maduke, Tarang Patel & Sofia Dias. (2022) Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and varying doses of inhaled corticosteroids in adolescents and adults with asthma: a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews 2022:12.
Crossref
Crossref
Ralph Brattsand & Olof Selroos. (2022) May a different kinetic mode explain the high efficacy/safety profile of inhaled budesonide?. Pulmonary Pharmacology & Therapeutics 77, pages 102167.
Crossref
Crossref
Orlagh O'Shea, Elizabeth Stovold & Christopher J Cates. (2021) Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. Cochrane Database of Systematic Reviews 2021:4.
Crossref
Crossref
Simon Wan Yau Ming, John Haughney, Iain Small, Stephanie Wolfe, John Hamill, Kevin Gruffydd-Jones, Cathal Daly, Joan B. Soriano, Elizabeth Gardener, Derek Skinner, Martina Stagno d'Alcontres & David B. Price. (2017) Initiating or changing to a fixed-dose combination of Fluticasone propionate/Formoterol over Fluticasone propionate/Salmeterol: A real-life effectiveness and cost impact evaluation. Respiratory Medicine 129, pages 199-206.
Crossref
Crossref
Iain Crossingham, David JW Evans, Nathan R Halcovitch & Paul A Marsden. (2017) Stepping down the dose of inhaled corticosteroids for adults with asthma. Cochrane Database of Systematic Reviews 2017:2.
Crossref
Crossref
Alberto PapiAdel H. MansurTetyana PertsevaKirsten KaiserTammy McIverBirgit GrotheSanjeeva Dissanayake. (2016) Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations. Journal of Aerosol Medicine and Pulmonary Drug Delivery 29:4, pages 346-361.
Crossref
Crossref
Eileen Wang & Flavia C.L. Hoyte. (2016) Traditional Therapies for Severe Asthma. Immunology and Allergy Clinics of North America 36:3, pages 581-608.
Crossref
Crossref
Tari Haahtela, Olof Selroos & Paul M. O'Byrne. (2015) Revisiting early intervention in adult asthma. ERJ Open Research 1:1, pages 00022-2015.
Crossref
Crossref
Chitra Dinakar, John Oppenheimer, Jay Portnoy, Leonard B. Bacharier, James Li, Carolyn M. Kercsmar, David Bernstein, Joann Blessing-Moore, David Khan, David Lang, Richard Nicklas, Christopher Randolph, Diane Schuller, Sheldon Spector, Stephen A. Tilles & Dana Wallace. (2014) Management of acute loss of asthma control in the yellow zone: a practice parameter. Annals of Allergy, Asthma & Immunology 113:2, pages 143-159.
Crossref
Crossref
Masayuki Hojo, Motoyasu Iikura, Junko Hirashima, Manabu Suzuki & Haruhito Sugiyama. (2014) A Comparison of Long-Term Anti-Inflammatory Effect of Two ICS/LABA Combination Inhalers; Fix-Dosed Maintenance Therapy with Budesonide/Formoterol and Salmeterol/Fluticasone. Allergology International 63:1, pages 103-111.
Crossref
Crossref
Ren? Aalbers. (2013) Single inhaler as maintenance and reliever therapy?is it SMART?. The Lancet Respiratory Medicine 1:1, pages 2-3.
Crossref
Crossref
Roland Buhl, Piotr Kuna, Matthew J Peters, Tomas LG Andersson, Ian P Naya, Stefan Peterson & Klaus F Rabe. (2012) The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy. Respiratory Research 13:1, pages 59.
Crossref
Crossref
Stephanie Korn & Roland Buhl. (2012) Efficacy of a fixed combination of ciclesonide and formoterol: The EXCITED-study. Respiratory Medicine 106:1, pages 57-67.
Crossref
Crossref
Toby J Lasserson, Giovanni Ferrara & Lucio Casali. (2011) Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Alex Thomas, Robert F. LemanskeJr.Jr. & Daniel J. Jackson. (2011) Approaches to stepping up and stepping down care in asthmatic patients. Journal of Allergy and Clinical Immunology 128:5, pages 915-924.
Crossref
Crossref
Geoff K. Frampton & Jonathan Shepherd. (2010) Patient-reported outcomes in clinical trials of inhaled asthma medications: systematic review and research needs. Quality of Life Research 20:3, pages 343-357.
Crossref
Crossref
René Aalbers. (2010) Fixed or Adjustable Maintenance-Dose Budesonide/Formoterol Compared with Fixed Maintenance-Dose Salmeterol/Fluticasone Propionate in Asthma Patients Aged ≥16 Years. Clinical Drug Investigation 30:7, pages 439-451.
Crossref
Crossref
Francine M Ducharme, Muireann Ni Chroinin, Ilana Greenstone & Toby J Lasserson. (2010) Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Francine M Ducharme, Muireann Ni Chroinin, Ilana Greenstone & Toby J Lasserson. (2010) Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Alan Kaplan & Dermot Ryan. (2010) The role of budesonide/formoterol for maintenance and relief in the management of asthma. Pulmonary Pharmacology & Therapeutics 23:2, pages 88-96.
Crossref
Crossref
Christopher J Cates & Toby J Lasserson. (2010) Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Mohammad Hamzavi. (2010) Combination Therapy with Budesonide and Formoterol in Single Inhaler of Asthma. Clinical Medicine Insights: Therapeutics 2, pages 1179559X1000200.
Crossref
Crossref
Muireann Ni Chroinin, Ilana Greenstone, Toby J Lasserson & Francine M Ducharme. (2009) Addition of long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Kate McKeage & Susan J. Keam. (2009) Salmeterol/Fluticasone Propionate. Drugs 69:13, pages 1799-1828.
Crossref
Crossref
Muireann Ni Chroinin, Toby J Lasserson, Ilana Greenstone & Francine M Ducharme. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Samy Suissa, Sophie Dell'Aniello & Pierre Ernst. (2009) Effectiveness of combination therapies in asthma: An observational study. Pulmonary Pharmacology & Therapeutics 22:3, pages 194-198.
Crossref
Crossref
J. Korsgaard & M. Ledet. (2009) Potential side effects in patients treated with inhaled corticosteroids and long-acting β2-agonists. Respiratory Medicine 103:4, pages 566-573.
Crossref
Crossref
Lucie Blais, Marie-France Beauchesne & Amélie Forget. (2009) Acute care among asthma patients using budesonide/formoterol or fluticasone propionate/salmeterol. Respiratory Medicine 103:2, pages 237-243.
Crossref
Crossref
M Van Den BergeNHT Ten HackenHAM KerstjensDS Postma. (2009) Management of Asthma with ICS and LABAs: Different treatment strategies. Clinical Medicine. Therapeutics 1, pages CMT.S2283.
Crossref
Crossref
Gary Rachelefsky. (2009) Inhaled Corticosteroids and Asthma Control in Children: Assessing Impairment and Risk. Pediatrics 123:1, pages 353-366.
Crossref
Crossref
Paul M. O'Byrne, Ian P. Naya, Anders Kallen, Dirkje S. Postma & Peter J. Barnes. (2008) Increasing Doses of Inhaled Corticosteroids Compared to Adding Long-Acting Inhaled β 2 -Agonists in Achieving Asthma Control. Chest 134:6, pages 1192-1199.
Crossref
Crossref
S. Aballéa, S. Cure, C. Vogelmeier & A. Wirén. (2008) A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting β2-agonists for asthma maintenance treatment in Germany. International Journal of Clinical Practice 62:12, pages 1870-1879.
Crossref
Crossref
M. Humbert, T. L. G. Andersson & R. Buhl. (2008) Budesonide/formoterol for maintenance and reliever therapy in the management of moderate to severe asthma. Allergy 63:12, pages 1567-1580.
Crossref
Crossref
Bertil Lindmark. (2008) Review: Differences in the pharmacodynamics of budesonide/formoterol and salmeterol/fluticasone reflect differences in their therapeutic usefulness in asthma. Therapeutic Advances in Respiratory Disease 2:5, pages 279-299.
Crossref
Crossref
N. B. Lazareva, A. I. Karlov & V. V. Arkhipov. (2008) Is there the alternative for high-dose inhaled corticosteroids to achieve asthma control?. PULMONOLOGIYA:4, pages 102-105.
Crossref
Crossref
Dirkje S. Postma, Huib A. M. Kerstjens & Nick H. T. ten Hacken. (2008) RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?. Naunyn-Schmiedeberg's Archives of Pharmacology 378:2, pages 203-215.
Crossref
Crossref
William W. Busse, Shailen R. Shah, Laura Somerville, Bhash Parasuraman, Paula Martin & Mitchell Goldman. (2008) Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. Journal of Allergy and Clinical Immunology 121:6, pages 1407-1414.e6.
Crossref
Crossref
Alyn H. Morice, Lude˘k Hochmuth, Jan Ekelund, Anders Thorén & Allan S. Puterman. (2008) Comparable long-term safety and efficacy of a novel budesonide/formoterol pressurized metered-dose inhaler versus budesonide/formoterol Turbuhaler® in adolescents and adults with asthma. Pulmonary Pharmacology & Therapeutics 21:1, pages 32-39.
Crossref
Crossref
Toby J Lasserson, Christopher J Cates, Giovanni Ferrara & Lucio Casali. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
N. P. Knyazheskaya. (2007) Budesonide / formoterol as an inhaler for basic therapy and relief of asthma symptoms (SMART strategy). PULMONOLOGIYA:6, pages 87-92.
Crossref
Crossref
David B Price, Angela E Williams & Sally Yoxall. (2007) Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life. Respiratory Research 8:1.
Crossref
Crossref
A. H. Morice, S. Peterson, O. Beckman & D. Osmanliev. (2007) Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma. International Journal of Clinical Practice 61:11, pages 1874-1883.
Crossref
Crossref
D. Price, A. Wirén & P. Kuna. (2007) Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy. Allergy 62:10, pages 1189-1198.
Crossref
Crossref
N. A. Gheppae, A. R. Denisova & N. I. Sokolova. (2007) News of combined therapy of moderate and severe asthma in children. PULMONOLOGIYA:4, pages 12-16.
Crossref
Crossref
H. William Kelly. (2007) Use of Budesonide/Formoterol Combination in a Single Inhaler for Maintenance and Relief Medication for Asthma: How Strong Is the Evidence?. Pediatric Asthma, Allergy & Immunology 20:2, pages 105-108.
Crossref
Crossref
A. Vergnen?gre & C. Choua?d. (2007) La strat?gie SMART est co?t-efficace (sous certaines conditions) dans le traitement de l?asthme. Revue des Maladies Respiratoires 24, pages 177-178.
Crossref
Crossref
P. Kuna, M. J. Peters, A. I. Manjra, C. Jorup, I. P. Naya, N. E. Martínez-Jimenez & R. Buhl. (2007) Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. International Journal of Clinical Practice 61:5, pages 725-736.
Crossref
Crossref
A. G. Chuchalin, A. N. Tsoy & V. V. Arkhipov. (2007) Symbicort (budesonide / formoterol) as a single inhaler for maintenance and reliever therapy of asthma. PULMONOLOGIYA:2, pages 98-103.
Crossref
Crossref
C. Marguet. (2007) Prise en charge de la crise d’asthme de l’enfant (nourrisson inclus). Revue des Maladies Respiratoires 24:4, pages 427-439.
Crossref
Crossref
Martyn R Partridge, Thys van der Molen, Sven-Erik Myrseth & William W Busse. (2006) Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulmonary Medicine 6:1.
Crossref
Crossref
H. William Kelly. (2006)
Budesonide/Formoterol Fumarate (Symbicort
?
)
. Pediatric Asthma, Allergy & Immunology 19:4, pages 243-246.
Crossref
Crossref
D. Blanquer Escribano & E. Sala Llins. (2006) Farmacolog?a de la enfermedad pulmonar obstructiva. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 9:63, pages 4097-4104.
Crossref
Crossref
M.C. Raux Demay, J.P. Magny, N. Idr?s, A. Grimfeld & Y. Le Bouc. (2006) Use of the Low-Dose Corticotropin Stimulation Test for the Monitoring of Children with Asthma Treated with Inhaled Corticosteroids. Hormone Research in Paediatrics 66:2, pages 51-60.
Crossref
Crossref
Christine JENKINS, Renata KOLARIKOVA, Piotr KUNA, Denis CAILLAUD, Joaquin SANCHIS, Wolfgang POPP & Eva PETTERSSON. (2006) Efficacy and safety of high-dose budesonide/formoterol (SymbicortR) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma. Respirology 11:3, pages 276-286.
Crossref
Crossref
W.R. Pohl, N. Vetter, H. Zwick & W. Hrubos. (2006) Adjustable maintenance dosing with budesonide/formoterol or budesonide: Double-blind study. Respiratory Medicine 100:3, pages 551-560.
Crossref
Crossref
Christopher M. Mjaanes, Glenn J. Whelan & Stanley J. Szefler. (2006) Corticosteroid Therapy in Asthma: Predictors of Responsiveness. Clinics in Chest Medicine 27:1, pages 119-132.
Crossref
Crossref
Hiroichi Nagai, Hitomi Teramachi & Teruo Tuchiya. (2006) Recent Advances in the Development of Anti-allergic Drugs. Allergology International 55:1, pages 35-42.
Crossref
Crossref
Anthony D D??Urzo. (2006) Inhaled Glucocorticosteroid and Long-Acting ??2-Adrenoceptor Agonist Single-Inhaler Combination for Both Maintenance and Rescue Therapy. Treatments in Respiratory Medicine 5:6, pages 385-391.
Crossref
Crossref
Nicola A Marks & Philip W Ind. 2005. Evidence‐based Respiratory Medicine. Evidence‐based Respiratory Medicine
217
230
.
P.-R. Burgel & J.-P. L’huillier. (2005) Nouvelles perspectives thérapeutiques dans l’asthme. Revue de Pneumologie Clinique 61:5, pages 16-19.
Crossref
Crossref
Muireann Ni Chroinin, Ilana IG Greenstone, Francine Ducharme, Vincent Masse & A Danish. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Ilana IG Greenstone, Muireann Ni Chroinin, Toby J Lasserson & Francine Ducharme. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Dave Singh & Ashley Woodcock. 2005. Pharmacotherapy of Asthma. Pharmacotherapy of Asthma
29
63
.
Shaun HOLT, Simon RYDER-LEWIS, Matthew MASOLI, Mark WEATHERALL & Richard BEASLEY. (2005) Fixed and adjustable dose asthma action plans based on combination therapy: A pilot study. Respirology 10:4, pages 497-503.
Crossref
Crossref
J. Mark FitzGerald, Louis-Philippe Boulet & Richard M.A. Follows. (2005) The authors' reply. Clinical Therapeutics 27:8, pages 1311-1315.
Crossref
Crossref
Bernd Brüggenjürgen, Dagmar Selim, Peter Kardos, Kai Richter, Claus Vogelmeier, Stephanie Roll, Wolfgang Meyer-Sabellek, Roland Buhl & Stefan N. Willich. (2012) Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthma. PharmacoEconomics 23:7, pages 723-731.
Crossref
Crossref
Graeme P. Currie, Daniel K.C. Lee & Andrew M. Wilson. (2005) Effects of dual therapy with corticosteroids plus long acting β2-agonists in asthma. Respiratory Medicine 99:6, pages 683-694.
Crossref
Crossref
Joaqu?n Sanchis. (2005) Asma. El control como meta del tratamiento. Medicina Cl?nica 124:13, pages 497-498.
Crossref
Crossref
M. Decramer & O. Selroos. (2005) Asthma and COPD: differences and similarities. International Journal of Clinical Practice 59:4, pages 385-398.
Crossref
Crossref
Harold S. Nelson. (2005) Combination therapy of long-acting β agonists and inhaled corticosteroids in the management of chronic asthma. Current Allergy and Asthma Reports 5:2, pages 123-129.
Crossref
Crossref
Paul M. O'ByrneHans BisgaardPhilippe P. GodardMassimo PistolesiMona PalmqvistYuanjue ZhuTommy EkströmEric D. Bateman. (2005) Budesonide/Formoterol Combination Therapy as Both Maintenance and Reliever Medication in Asthma. American Journal of Respiratory and Critical Care Medicine 171:2, pages 129-136.
Crossref
Crossref
Muireann Ni Chroinin, Ilana IG Greenstone & Francine Ducharme. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
J.M. Fitzgerald, P. Olsson & A. Michils. (2004) Adjustable maintenance dosing with budesonide/formoterol in a single inhaler - efficacy and safety. International Journal of Clinical Practice 58, pages 18-25.
Crossref
Crossref
G.W. Canonica & A.M. Vignola. (2004) Adjustable maintenance dosing: suitability of budesonide/formoterol in a single inhaler and overview of a clinical study programme. International Journal of Clinical Practice 58, pages 9-17.
Crossref
Crossref
Stanley J Szefler. (2004) Current concepts in asthma treatment in children. Current Opinion in Pediatrics 16:3, pages 299-304.
Crossref
Crossref
K Fan Chung & Ian M Adcock. (2004) Combination Therapy of Long-Acting ??2-Adrenoceptor Agonists and Corticosteroids for Asthma. Treatments in Respiratory Medicine 3:5, pages 279-289.
Crossref
Crossref